Literature DB >> 14577492

Screening for prostate cancer in Romania.

Raphaela Waidelich1, Gheorghe Bumbu, Marius Raica, Marieta Toma, Teodor Maghiar, Alfons Hofstetter.   

Abstract

In Romania, more than 95% of patients present with advanced stage prostate cancer at the time of diagnosis. Our purpose was to detect early prostate cancer in the Romanian city of Oradea, with a screening based on digital rectal examination and fine needle aspiration biopsy. We performed digital rectal examinations on 701 men, between 50 to 80 years of age. Four men with a history of prostate cancer were excluded from the study. Transrectal fine-needle aspiration biopsies were done in 15 men who presented with suspicious findings at the digital rectal examination. Prostate cancer was cytologically proven in eleven men. Nine of these were low- to intermediate grade (GI-II) and clinically localized (T2). Two patients had clinical stage T3 tumors. The prostate cancer detection rate in the screened population was 1.6% (11/697). Currently, eight men have undergone total retropubic prostatectomy. One patient presented with pelvic lymph node metastases and, after a staging lymphadenectomy, only a bilateral orchiectomy was performed. This first Romanian mass screening study for prostate cancer revealed a great interest in early cancer detection among the general public. Continued effort to make asymptomatic men aware of the disease may ultimately lead to an overall stage reduction at the time of diagnosis in Romania.

Entities:  

Mesh:

Year:  2002        PMID: 14577492     DOI: 10.1023/a:1025627204632

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  20 in total

1.  Variation in survival of patients with prostate cancer in Europe since 1978. EUROCARE Working Group.

Authors:  P N Post; R A Damhuis; A P van der Meyden
Journal:  Eur J Cancer       Date:  1998-12       Impact factor: 9.162

2.  Eight years of "Prostate Cancer Awareness Week": lessons in screening and early detection. Prostate Cancer Education Council.

Authors:  E P DeAntoni
Journal:  Cancer       Date:  1997-11-01       Impact factor: 6.860

3.  Fine needle aspiration biopsy of the prostate gland: a study of 103 cases with histological followup.

Authors:  B M Ljung; R Cherrie; J J Kaufman
Journal:  J Urol       Date:  1986-05       Impact factor: 7.450

4.  Cytologic malignancy grading of prostatic carcinoma by transrectal aspiration biopsy. A five-year follow-up study of 469 hormone-treated patients.

Authors:  P L Esposti
Journal:  Scand J Urol Nephrol       Date:  1971

5.  Cancer statistics, 1999.

Authors:  S H Landis; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1999 Jan-Feb       Impact factor: 508.702

6.  The European Randomized Study of Screening for Prostate Cancer (ERSPC): an update. Members of the ERSPC, Section Rotterdam.

Authors:  F H Schröder; R Kranse; J Rietbergen; R Hoedemaeke; W Kirkels
Journal:  Eur Urol       Date:  1999       Impact factor: 20.096

7.  The results of prostate carcinoma screening in the U.S. as reflected in the surveillance, epidemiology, and end results program.

Authors:  C R Smart
Journal:  Cancer       Date:  1997-11-01       Impact factor: 6.860

Review 8.  Prostate specific antigen: a decade of discovery--what we have learned and where we are going.

Authors:  T J Polascik; J E Oesterling; A W Partin
Journal:  J Urol       Date:  1999-08       Impact factor: 7.450

9.  Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

Authors:  William J Catalona; Jerome P Richie; Frederick R Ahmann; M'Liss A Hudson; Peter T Scardino; Robert C Flanigan; Jean B DeKernion; Timothy L Ratliff; Louis R Kavoussi; Bruce L Dalkin; W Bedford Waters; Michael T MacFarlane; Paula C Southwick
Journal:  J Urol       Date:  1994-05       Impact factor: 7.450

10.  A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer.

Authors:  P H Gann; C H Hennekens; M J Stampfer
Journal:  JAMA       Date:  1995-01-25       Impact factor: 56.272

View more
  1 in total

1.  Profile of common prostate cancer risk variants in an unscreened Romanian population.

Authors:  Paul D Iordache; Dana Mates; Bjarni Gunnarsson; Hannes P Eggertsson; Patrick Sulem; Júlíus Guðmundsson; Stefania Benónísdóttir; Irma Eva Csiki; Stefan Rascu; Daniel Radavoi; Radu Ursu; Catalin Staicu; Violeta Calota; Angelica Voinoiu; Mariana Jinga; Gabriel Rosoga; Razvan Danau; Sorin Cristian Sima; Daniel Badescu; Nicoleta Suciu; Viorica Radoi; Andrei Manolescu; Thorunn Rafnar; Bjarni V Halldórsson; Viorel Jinga; Kári Stefánsson
Journal:  J Cell Mol Med       Date:  2017-12-20       Impact factor: 5.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.